Moderna filed for conditional Marketing Approval for its COVID-19 vaccine in adolescents in the EU
On Jun. 7, 2021, Moderna announced that it had submitted for a conditional marketing approval (CMA) for its…
On Jun. 7, 2021, Moderna announced that it had submitted for a conditional marketing approval (CMA) for its…
On Jun. 7, 2021, Moderna announced a new agreement to commercialize its COVID-19 Vaccine across Central Eastern Europe…
On Jun. 7, 2021, OraSure Technologies announced that it had received Emergency Use Authorization (EUA) from the FDA…
On Jun. 4, 2021, the U.S. Food and Drug Administration announced it had approved Novo Nordisk’s Wegovy (semaglutide)…
On Jun. 4, 2021, the U.S. Food and Drug Administration approved Novo Nordisk’s Wegovy (semaglutide) injection (2.4 mg…
On Jun. 4, 2021, Chimerix announced that the U.S. Food and Drug Administration (FDA) had granted TEMBEXAᆴ (brincidofovir)…
On Jun. 4, 2021, Regeneron announced the U.S. Food and Drug Administration (FDA) updated the Emergency Use Authorization…
On Jun. 3, 2021, Resverlogix announced a partnership to support planned commercialization of apabetalone in the United States,…
On Jun. 3, 2021, the National Institutes of Health announced that the experimental drug TEMPOL may be a…
On Jun. 3, 2021, Innovation Pharma announced that it had achieved full patient enrollment in its randomized, double-blind,…
On Jun. 3, 2021, Moder’s vaccine against COVID-19, to support the government’s ongoing efforts to secure access to…
On Jun. 2, 2021, Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration extended the…
On Jun. 2, 2021, RELIEF THERAPEUTICS reported that its collaboration partner, NRx Pharmaceuticals, announced that it had submitted…
On Jun. 2, 2021, Moderna and UNICEF announced that they had signed a long-term agreement for the supply…
On Jun. 2, 2021, Vaxxas announced that research demonstrated the potential of Vaxxasメ novel high-density microarray patch (HD-MAP)…
On Jun. 1, 2021, the National Institutes of Health (NIH) announced the first-in-human, Phase 1 trial assessing the…
On Jun. 1, 2021, in a study of 11 medical-mystery patients, an international team of researchers led by…
On Jun. 1, 2021, Sanofi announced that Vaxelis (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus…
On Jun. 1, 2021, a study by researchers at the National Institutes of Health and their colleagues found…
On Jun. 1, 2021, WHO validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies…
On Jun. 1, 2021, the heads of the world’s predominant global financing, health and trade agencies united to…
On Jun. 1, 2021, the National Institutes of Health announced that it had started a Phase 1/2 clinical…
On Jun. 1, 2021, the WHO announced it had validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving…
On Jun. 1, 2021, AquaBounty Technologies announced the regulatory approval of the Company’s GE Atlantic salmon by Brazil’s…
On Jun. 1, 2021, Moderna announced that it had initiated the rolling submission process with the U.S. Food…
On Jun. 1, 2021, Moderna announced that it had entered into an agreement with Thermo Fisher Scientific for…
On Jun. 1, 2021, CytoDyn announced that Chiral Pharma in the Philippines placed its first purchase order for…
On Jun. 1, 2021, the U.S. Department of Health and Human Services (HHS) unveiled a new type of…
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
On May 28, 2021, CureVac announced that the independent Data Safety Monitoring Board (DSMB)confirmed that the pivotal Phase…